BFG
GMAB icon

Bleakley Financial Group’s Genmab GMAB Stock Holding History

Bleakley Financial Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,732
Closed -$749K – 1069
2024
Q3 		$749K Buy
30,732
+2,196
+8% +$58.7K 0.02% 481
2024
Q2 		$717K Sell
28,536
-1,699
-6% -$48.2K 0.02% 498
2024
Q1 		$904K Buy
30,235
+7,822
+35% +$230K 0.03% 453
2023
Q4 		$714K Sell
22,413
-1,561
-7% -$49K 0.02% 495
2023
Q3 		$846K Sell
23,974
-475
-2% -$18.1K 0.03% 413
2023
Q2 		$929K Sell
24,449
-537
-2% -$21.4K 0.03% 418
2023
Q1 		$943K Buy
24,986
+2,827
+13% +$109K 0.03% 396
2022
Q4 		$939K Buy
+22,159
New +$913K 0.03% 389

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bleakley Financial Group's GMAB Position: Q4 2024 in Review

Bleakley Financial Group sold out of Genmab (GMAB) in Q4 2024, closing a stake of 30,732 shares — an estimated $749K sold.

Bleakley Financial Group first reported a position in GMAB in Q4 2022 and held it in 8 quarters. The position peaked at $943K in Q1 2023. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

  • Bleakley Financial Group reported no remaining Genmab position as of Q4 2024 after selling out during the quarter.
  • Bleakley Financial Group sold 30,732 Genmab shares in Q4 2024, an estimated $749K.
  • Bleakley Financial Group first reported a position in Genmab in Q4 2022 and held it in 8 quarters.
  • Bleakley Financial Group's Genmab position peaked at $943K in Q1 2023.
  • 228 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on Bleakley Financial Group's 13F filing for Q4 2024, filed 27 Jan 2025.